[1] |
中国疾病预防控制中心性病控制中心, 中华医学会皮肤性病学分会性病学组, 中国医师协会皮肤科医师分会性病亚专业委员会. 梅毒、淋病和生殖道沙眼衣原体感染诊疗指南(2020年)[J]. 中华皮肤科杂志, 2020,53(3):168⁃179. doi: 10.35541/cjd.20190808.
|
[2] |
Ghanem KG, Ram S, Rice PA. The modern epidemic of syphilis[J]. N Engl J Med, 2020,382(9):845⁃854. doi: 10.1056/NEJM ra1901593.
|
[3] |
Tuddenham S, Katz SS, Ghanem KG. Syphilis laboratory guidelines: performance characteristics of nontreponemal antibody tests[J]. Clin Infect Dis, 2020,71(Suppl 1):S21⁃S42. doi: 10. 1093/cid/ciaa306.
|
[4] |
Davis AP, Stern J, Tantalo L, et al. How well do neurologic symptoms identify individuals with neurosyphilis?[J]. Clin Infect Dis, 2018,66(3):363⁃367. doi: 10.1093/cid/cix799.
|
[5] |
Janier M, Unemo M, Dupin N, et al. 2020 European guideline on the management of syphilis[J]. J Eur Acad Dermatol Venereol, 2021,35(3):574⁃588. doi: 10.1111/jdv.16946.
|
[6] |
Park IU, Fakile YF, Chow JM, et al. Performance of treponemal tests for the diagnosis of syphilis[J]. Clin Infect Dis, 2019,68(6):913⁃918. doi: 10.1093/cid/ciy558.
|
[7] |
Marra CM, Maxwell CL, Dunaway SB, et al. Cerebrospinal fluid Treponema pallidum particle agglutination assay for neurosyphilis diagnosis[J]. J Clin Microbiol, 2017,55(6):1865⁃1870. doi: 10. 1128/JCM.00310⁃17.
|
[8] |
Park IU, Tran A, Pereira L, et al. Sensitivity and specificity of treponemal⁃specific tests for the diagnosis of syphilis[J]. Clin Infect Dis, 2020,71(Suppl 1):S13⁃S20. doi: 10.1093/cid/ciaa349.
|
[9] |
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021[J]. MMWR Recomm Rep, 2021,70(4):1⁃187. doi: 10.15585/mmwr.rr7004a1.
|
[10] |
Marra CM. Alternatives to the cerebrospinal fluid venereal disease research laboratory test for neurosyphilis diagnosis[J]. Sex Transm Dis, 2021,48(8S):S54⁃S57. doi: 10.1097/OLQ.000 0000000001450.
|
[11] |
Zhu L, Gu X, Peng RR, et al. Comparison of the cerebrospinal fluid (CSF) toluidine red unheated serum test and the CSF rapid plasma reagin test with the CSF venereal disease research laboratory test for diagnosis of neurosyphilis among HIV⁃negative syphilis patients in China[J]. J Clin Microbiol, 2014,52(3):736⁃740. doi: 10.1128/JCM.02522⁃13.
|
[12] |
Marks M, Lawrence D, Kositz C, et al. Diagnostic performance of PCR assays for the diagnosis of neurosyphilis: a systematic review[J]. Sex Transm Infect, 2018,94(8):585⁃588. doi: 10. 1136/sextrans⁃2018⁃053666.
|
[13] |
Gudowska⁃Sawczuk M, Mroczko B. Chemokine ligand 13 (CXCL13) in neuroborreliosis and neurosyphilis as selected spirochetal neurological diseases: a review of its diagnostic significance[J]. Int J Mol Sci, 2020,21(8):2927. doi: 10.3390/ijms21082927.
|
[14] |
Wang C, Wu K, Yu Q, et al. CXCL13, CXCL10 and CXCL8 as potential biomarkers for the diagnosis of neurosyphilis patients[J]. Sci Rep, 2016,6:33569. doi: 10.1038/srep33569.
|
[15] |
Levchik N, Ponomareva M, Surganova V, et al. Criteria for the diagnosis of neurosyphilis in cerebrospinal fluid: relationships with intrathecal immunoglobulin synthesis and blood⁃cerebrospinal fluid barrier dysfunction[J]. Sex Transm Dis, 2013,40(12):917⁃922. doi: 10.1097/OLQ.0000000000000049.
|
[16] |
Kingston M, French P, Higgins S, et al. UK national guidelines on the management of syphilis 2015[J]. Int J STD AIDS, 2016,27(6):421⁃446. doi: 10.1177/0956462415624059.
|
[17] |
Dunaway SB, Maxwell CL, Tantalo LC, et al. Neurosyphilis treatment outcomes after intravenous penicillin G versus intramuscular procaine penicillin plus oral probenecid[J]. Clin Infect Dis, 2020,71(2):267⁃273. doi: 10.1093/cid/ciz795.
|
[18] |
Liu LL, Zhang HL, Huang SJ, et al. Assessing cerebrospinal fluid abnormalities in neurosyphilis patients without human immunodeficiency virus infection[J]. Int Immunopharmacol, 2013,17(4):1120⁃1124. doi: 10.1016/j.intimp.2013.10.008.
|
[19] |
Lu Y, Ke W, Yang L, et al. Clinical prediction and diagnosis of neurosyphilis in HIV⁃negative patients: a case⁃control study[J]. BMC Infect Dis, 2019,19(1):1017. doi: 10.1186/s12879⁃019⁃4582⁃2.
|
[20] |
Wu S, Ye F, Wang Y, et al. Neurosyphilis: insights into its pathogenesis, susceptibility, diagnosis, treatment, and prevention[J]. Front Neurol, 2023,14:1340321. doi: 10.3389/fneur.2023. 1340321.
|
[21] |
Zhou J, Zhang H, Tang K, et al. An updated review of recent advances in neurosyphilis[J]. Front Med (Lausanne), 2022,9:800383. doi: 10.3389/fmed.2022.800383.
|